摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

carbonic acid chloromethyl ester-trichloromethyl ester

中文名称
——
中文别名
——
英文名称
carbonic acid chloromethyl ester-trichloromethyl ester
英文别名
α.α.α.α'-Tetrachlor-dimethylcarbonat;Kohlensaeure-chlormethylester-trichlormethylester;Chlormethyl-trichlormethyl-carbonat;asymm.Tetrachlordimethylcarbonat;Chloromethyl trichloromethyl carbonate;chloromethyl trichloromethyl carbonate
carbonic acid chloromethyl ester-trichloromethyl ester化学式
CAS
——
化学式
C3H2Cl4O3
mdl
——
分子量
227.859
InChiKey
MBUKGHPBLCCGCD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    10
  • 可旋转键数:
    3
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.67
  • 拓扑面积:
    35.5
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • METHODS AND COMPOSITIONS FOR MAKING AN AMINO ACID TRIISOCYANATE
    申请人:Warsaw Orthopedic, Inc.
    公开号:US20150197488A1
    公开(公告)日:2015-07-16
    A method of making an amino acid triisocyanate is provided, the method comprising reacting an amino acid trihydrochloride with phosgene to form the amino acid triisocyanate. In some embodiments, the amino acid trihydrochloride comprises lysine ester trihydrochloride salt and the amino acid triisocyanate comprises lysine ester triisocyanate. In some embodiments, there is a lysine ester triisocyanate having a purity of at least about 98%, the lysine ester triisocyanate having a structure resulting from reacting lysine ester trihydrochloride salt with phosgene to form the lysine ester triisocyanate. These lysine ester triisocyanates can be used to make biodegradable polyurethanes.
    提供了一种制备氨基酸三异氰酸酯的方法,该方法包括将氨基酸三氢氯酸盐与光气反应以形成氨基酸三异氰酸酯。在一些实施例中,氨基酸三氢氯酸盐包括赖氨酸酯三氢氯酸盐,而氨基酸三异氰酸酯包括赖氨酸酯三异氰酸酯。在一些实施例中,存在一种纯度至少约为98%的赖氨酸酯三异氰酸酯,该赖氨酸酯三异氰酸酯具有由赖氨酸酯三氢氯酸盐与光气反应形成赖氨酸酯三异氰酸酯的结构。这些赖氨酸酯三异氰酸酯可用于制造生物降解聚氨酯。
  • STABLE PEPTIDE-BASED FURIN INHIBITORS
    申请人:Day Robert
    公开号:US20150141324A1
    公开(公告)日:2015-05-21
    It is provided furin inhibitors and their uses for treating pathogen infection. Particularly, it is provided a method or use for the treatment of a pathogen infection, in a subject, comprising administering to the subject a therapeutically effective amount of the furin inhibitors or the composition disclosed, thereby preventing or treating pathogen infection, in the subject.
    本发明提供了抑制酶furin及其用于治疗病原体感染的方法。特别地,本发明提供了一种治疗主体的病原体感染的方法或用途,包括向该主体投予治疗有效量的furin抑制剂或所披露的组合物,从而预防或治疗该主体的病原体感染。
  • STABLE PEPTIDE-BASED PACE4 INHIBITORS
    申请人:Day Robert
    公开号:US20140206622A1
    公开(公告)日:2014-07-24
    It is provided PACE4 inhibitors and their uses for treating infection, cancer. Particularly, it is provided a method or use for the treatment of a cancer in a subject, comprising administering to the subject a therapeutically effective amount of the PACE4 inhibitors or the composition disclosed.
    本文提供了PACE4抑制剂及其用于治疗感染和癌症的方法。特别地,本文提供了一种用于治疗患者癌症的方法或用途,包括向患者施用足够治疗量的PACE4抑制剂或所述的组合物。
  • FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS
    申请人:Gilead Sciences, Inc.
    公开号:US20160362421A1
    公开(公告)日:2016-12-15
    The present disclosure relates to compounds that are sodium channel inhibitors and to their use in the treatment of various disease states, including cardiovascular diseases and diabetes. In particular embodiments, the structure of the compounds is given by Formula I: wherein Q, R 1 , X 1 , X 2 , Y and R 2 are as described herein, to methods for the preparation and use of the compounds and to pharmaceutical compositions containing the same.
  • US9115096B2
    申请人:——
    公开号:US9115096B2
    公开(公告)日:2015-08-25
查看更多